Algernon Pharmaceuticals Announces Ifenprodil (NP-120) an NDMA Receptor Antagonist as its Lead Drug That Reduced Fibrosis in a Recent Idiopathic Pulmonary Fibrosis Study by 56%

Algernon Pharmaceuticals Inc. (CSE:AGN) is pleased to announce that NP-120, its lead compound in its idiopathic pulmonary fibrosis (IPF) research...